Literature DB >> 16007153

Mitochondrial localization of p53 during adenovirus infection and regulation of its activity by E1B-19K.

Elena Lomonosova1, T Subramanian, G Chinnadurai.   

Abstract

Recent results have revealed that the p53 tumor suppressor protein possesses a direct transcription-independent apoptotic activity. During apoptosis induced by genotoxic stress, a small fraction of p53 is targeted to mitochondria where it initiates apoptosis by causing mitochondrial dysfunction. In adenovirus-infected cells, the expression of E1A protein enhances the accumulation of p53 during early phases of infection and during late times after infection, it is targeted for degradation by the combined action of E1B-55K and E4-orf6 proteins. The functional significance of E1A-mediated accumulation of p53 during early phases of viral replication is not known. Our studies with isogenic epithelial cell lines that differ only on the status of p53 indicate that Ad infection induces apoptosis by p53-dependent and -independent pathways and both pathways are suppressed by E1B-19K. We show that during early phase of Ad infection, a fraction of p53 is targeted to the mitochondria. In virus infected cells, a large fraction of the viral antiapoptosis protein E1B-19K is also localized in mitochondria during early and late phases of infection. Coimmunoprecipitation analysis has revealed that p53 and E1B-19K form a complex in mitochondria. The interaction of 19K involves two noncontiguous regions located around amino-acid residues 14-15 and 123-124. On p53, the mutations within the DNA-binding domain reduce interaction with E1B-19K. Our studies also suggest that 19K may additionally complex with the multidomain mitochondrial proapoptotic protein BAK, thereby reducing the level of p53 interaction with BAK. We suggest that p53-induced apoptosis may be important for efficient cell lysis and viral spread and that E1B-19K may neutralize the apoptotic activity of p53 at multiple levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007153     DOI: 10.1038/sj.onc.1208836

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.

Authors:  Ilya V Ulasov; Mathew A Tyler; Zeng B Zhu; Yu Han; Tong-Chuan He; Maciej S Lesniak
Journal:  Int J Oncol       Date:  2009-03       Impact factor: 5.650

2.  Human Adenovirus Core Protein V Is Targeted by the Host SUMOylation Machinery To Limit Essential Viral Functions.

Authors:  Nora Freudenberger; Tina Meyer; Peter Groitl; Thomas Dobner; Sabrina Schreiner
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 3.  Viral product trafficking to mitochondria, mechanisms and roles in pathogenesis.

Authors:  Chad D Williamson; Roberta L DeBiasi; Anamaris M Colberg-Poley
Journal:  Infect Disord Drug Targets       Date:  2012-02

4.  FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies.

Authors:  Kristijana Milovic-Holm; Eva Krieghoff; Kirsten Jensen; Hans Will; Thomas G Hofmann
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

Review 5.  Long story short: p53 mediates innate immunity.

Authors:  Jessica Miciak; Fred Bunz
Journal:  Biochim Biophys Acta       Date:  2016-03-04

6.  Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo.

Authors:  Stephan Leitner; Katrina Sweeney; Daniel Oberg; Derek Davies; Enrique Miranda; Nick R Lemoine; Gunnel Halldén
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

7.  Adenovirus E1A and E1B-19K proteins protect human hepatoma cells from transforming growth factor beta1-induced apoptosis.

Authors:  Vera L Tarakanova; William S M Wold
Journal:  Virus Res       Date:  2009-10-23       Impact factor: 3.303

8.  Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells.

Authors:  Fang Wei; Huiping Wang; Xiafang Chen; Chuanyuan Li; Qian Huang
Journal:  Cancer Biol Ther       Date:  2014-07-14       Impact factor: 4.742

9.  Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers.

Authors:  Daniel Oberg; Eva Yanover; Virginie Adam; Katrina Sweeney; Celina Costas; Nick R Lemoine; Gunnel Halldén
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

10.  BAX/BAK-independent mitoptosis during cell death induced by proteasome inhibition?

Authors:  Elena Lomonosova; Jan Ryerse; G Chinnadurai
Journal:  Mol Cancer Res       Date:  2009-08-11       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.